Company / Profit Margin
IDEAYA Biosciences, Inc. Profit Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-52.0%
FY2025
5-year range
-3921.1% / -52.0%
FY2021-FY2025
Trend
+98.7%
vs FY2024
Sector context
#90 of 145
Health Care
What the data says
At -52.0%, IDEAYA Biosciences, Inc.'s profit margin ranks #90 of 145 in the Health Care sector. Profit Margin returned to growth in FY2025 after 3 years of decline, reaching -52.0%.
Based on SEC 10-K filings.
-52.0% in FY2025 with a 5-year CAGR of +123.8%.
Improved from -483.0% to -52.0% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +124.6pp
- 5-Year Change
- +123.8pp
- 10-Year Change
- -
Sector benchmark
#90 of 145 in Health CareTop 62% of 145This company -52.0% Sector average -792.7%
▼
+93.4% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 98.7% year-over-year.
- Currently 740.7pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -52.0% | +98.7% |
| FY2024 | -3921.1% | -711.7% |
| FY2023 | -483.0% | -173.6% |
| FY2022 | -176.6% | - |
| FY2021 | - | - |
| FY2020 | -175.8% | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026